Matthew Angel

TPST

Matthew Angel serves as director, 10 percent owner, officer: CEO and President at Tempest Therapeutics, Inc. (TPST). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$500.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$500.0K

Companies Traded

TPST

Active Period

Mar 2026

1 total trades

Most Recent

Buy TPST

Mar 25, 2026 · $500.0K

Matthew Angel's Insider Trading at Tempest Therapeutics, Inc. (TPST)

Buys

1 · $500.0K

Sells

0 · $0.00

Total Shares Bought

231,482

Total Shares Sold

TPST Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 25, 2026	Buy	231,482	$2.16	$500.0K	231,482

Explore More Insider Trading Data

TPST Insider Trading Activity

View all insider trades at Tempest Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity